Clin2
NCT06545877Likely a fitRecruiting

Survey of REKOVELLE for fertility treatment

Infertility

Part of Women’s health & pregnancy clinical trials.

This survey collects information from people who have already used REKOVELLE (a medication that helps the ovaries produce eggs) as part of their fertility treatment. Taking part will help researchers learn how the medication works in real-world daily practice.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
Any age
Study type
Observational

Who can take part

  • Must have been treated with REKOVELLE (a fertility medication) for controlled ovarian stimulation (helping your ovaries produce eggs) during an assisted reproductive technology procedure like IVF or ICSI.
  • Must have agreed to participate in the survey about your experience with this medication.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07029451Recruiting
Study of REKOVELLE for first-time IVF or ICSI in Chinese women

This study looks at how well the medication REKOVELLE works for Chinese women going through their first IVF or ICSI cycle. It will track real-world results, safety, and how the medication is used. It may help if you are starting IVF or ICSI for the first time.

Hefei, Anhui
NCT07153367Recruiting· Phase 2
Study of a fixed dose of Rekovelle for IUI treatment

This trial tests a fixed dose of the hormone follitropin delta (Rekovelle) to stimulate the ovaries before intrauterine insemination (IUI). It aims to see if this approach works well for women with regular cycles who are starting IUI for the first time.

Bruges
NCT06023602Recruiting
Generic vs. brand-name cetrorelix for IVF ovarian stimulation

This trial compares a generic version of cetrorelix acetate (a medication used to control ovulation) to the brand-name version during IVF. It aims to see if the generic works just as well for women undergoing ovarian stimulation.

Xi'an, None Selected
NCT07553728Not yet recruiting
Fertility Treatment Safety Study in Women Ages 36–40

This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.

Beijing, Beijing Municipality
NCT05173597Recruiting
Real-world study of follitropin delta dosing in IVF

This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.

Lübeck, Schleswig-Holstein
NCT06997900Recruiting· Phase 2
Combination of Menopur and Rekovelle for first IVF cycle

This study tests a combination of two fertility medications (Menopur and Rekovelle) to see if they work well together during your first IVF cycle. It may be a good option if you have certain types of infertility and meet the health requirements.

Ottawa, Ontario

Hear when a new Infertility trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.